Scientific References
1.Pharmacologic inhibition of JAK-STAT signaling promotes hair growth.
2.The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride.
3.5α-Reductase isozymes and aromatase mRNA levels in plucked hair from young women with female pattern hair loss.
https://link.springer.com/article/10.1007%2Fs00403-017-1798-0
4.The Role of Vitamins and Minerals in Hair Loss: A Review.
5.Disorders of hair growth. Diagnosis and treatment. McGraw Hill, New York 2003: 321-362
6.Male pattern androgenetic alopecia. BMJ. 1998; 317: 865-869
7.Wilson J.D. Griffin J.E. Russell D.W. Steroid 5 alpha-reductase 2 deficiency. Endocr Rev. 1993; 14: 577-593
8.Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol. 1998; 39: 578-589
9.Predominance of type I 5alpha-reductase in apocrine sweat glands of patients with excessive or abnormal odour derived from apocrine sweat (osmidrosis). Br J Dermatol. 1998; 139: 806-810
10.Immunocytochemical localization of human 5 alpha-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues. J Histochem Cytochem. 1994; 42: 667-675
11.Debruyne F. Barkin J. van Erps P. Reis M. Tammela T. Roehrborn C. et al. Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia. Eur Urol. 2004; 46: 488-495